These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36935073)

  • 1. Intratracheally administered iron oxide nanoparticles induced murine lung inflammation depending on T cells and B cells.
    Sun Y; Chen Y; Wang J; Yuan W; Xue R; Li C; Xia Q; Hu L; Wei Y; He M; Lai K
    Food Chem Toxicol; 2023 May; 175():113735. PubMed ID: 36935073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute iron oxide nanoparticles exposure induced murine eosinophilic airway inflammation via TLR2 and TLR4 signaling.
    Yue L; Qidian L; Jiawei W; Rou X; Miao H
    Environ Toxicol; 2022 Apr; 37(4):925-935. PubMed ID: 34982504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease.
    Donovan C; Starkey MR; Kim RY; Rana BMJ; Barlow JL; Jones B; Haw TJ; Mono Nair P; Budden K; Cameron GJM; Horvat JC; Wark PA; Foster PS; McKenzie ANJ; Hansbro PM
    J Leukoc Biol; 2019 Jan; 105(1):143-150. PubMed ID: 30260499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
    Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
    Front Immunol; 2020; 11():1058. PubMed ID: 32582171
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
    Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
    J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing ST2
    Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
    J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4
    Wu Y; Shi W; Wang H; Yue J; Mao Y; Zhou W; Kong X; Guo Q; Zhang L; Xu P; Wang Y
    Int J Nanomedicine; 2020; 15():9745-9758. PubMed ID: 33299314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung.
    Tei R; Iijima K; Matsumoto K; Kobayashi T; Lama J; Jacobsen EA; Kita H
    J Allergy Clin Immunol; 2022 Mar; 149(3):1044-1059.e5. PubMed ID: 34428519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice.
    Matsuda M; Tanaka Y; Shimora H; Takemoto N; Nomura M; Terakawa R; Hashimoto K; Sakae H; Kanda A; Iwai H; Kitatani K; Nabe T
    Eur J Pharmacol; 2022 Feb; 916():174732. PubMed ID: 34971621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor.
    Wang YM; Shaw K; Zhang GY; Chung EYM; Hu M; Cao Q; Wang Y; Zheng G; Wu H; Chadban SJ; McCarthy HJ; Harris DCH; Mackay F; Grey ST; Alexander SI
    J Am Soc Nephrol; 2022 May; 33(5):966-984. PubMed ID: 35387873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group 2 innate lymphoid cells in nasal polyposis.
    Stevens WW; Kato A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
    Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
    J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
    Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
    J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ constrains cytokine production of group 2 innate lymphoid cells.
    Kudo F; Ikutani M; Seki Y; Otsubo T; Kawamura YI; Dohi T; Oshima K; Hattori M; Nakae S; Takatsu K; Takaki S
    Immunology; 2016 Jan; 147(1):21-9. PubMed ID: 26425820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
    Mathä L; Shim H; Steer CA; Yin YH; Martinez-Gonzalez I; Takei F
    PLoS One; 2019; 14(3):e0214286. PubMed ID: 30913260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor RelB restrains group 2 innate lymphoid cells and type 2 immune pathology in vivo.
    Zhang L; Ying Y; Chen S; Arnold PR; Tian F; Minze LJ; Xiao X; Li XC
    Cell Mol Immunol; 2021 Jan; 18(1):230-242. PubMed ID: 32203192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
    Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
    Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells control innate immune reactivity after injury.
    Murphy TJ; Ni Choileain N; Zang Y; Mannick JA; Lederer JA
    J Immunol; 2005 Mar; 174(5):2957-63. PubMed ID: 15728508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
    Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
    Front Immunol; 2022; 13():930862. PubMed ID: 35911708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.